The DOI matches its Crossref record.
Detection of Occult Bone Marrow Micrometastases in Patients with Operable Lung Carcinoma
Open accessAbstract
OBJECTIVES: A large proportion of patients with operable lung carcinoma (no evidence of systemic spread of tumor) develop metastatic disease after primary therapy. More sensitive and specific methods are needed to identify patients at highest risk for recurrence who may benefit most from adjuvant therapy, while sparing those patients who do not require such treatment. SUMMARY BACKGROUND DATA: Using epithelial-specific monoclonal antibodies, the authors have developed an immunocytochemical assay capable of detecting as few as 2 lung cancer cells in 1 million bone marrow cells. METHODS: The assay was used to test the bone marrow (from resected ribs) of 43 patients with primary non-small cell lung carcinoma who showed no clinical or pathologic evidence of systemic disease. RESULTS: Occult bone marrow micrometastases (BMMs) were detected in 40% of patients (17/43) with non-small cell lung cancer, including 29% (5/17) of patients with stage I or II disease and 46% of whom (12/26) had stage III disease. The median follow-up was 13.6 months. Patients with occult BMMs had significantly shorter times to disease recurrence compared with patients without BMMs (7.3 vs. > 35.1 months, p = 0.0009). Furthermore, for patients with stage I or II disease, the presence of occult BMMs was significantly associated with a higher rate of recurrence (p = 0.0004). CONCLUSIONS: The detection of occult BMMs identifies patients with operable non-small cell lung carcinoma who are at significantly increased risk for recurrence, independent of tumor stage, and may be useful in evaluating patients for adjuvant treatment protocols.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Noninvasive Staging of Non-small Cell Lung Cancer*
Toloza, E. M., Harpole, L., & McCrory, D. C. (2003) · Chest · doi:10.1378/chest.123.1_suppl.137s · Cited by 745
Noninvasive Staging of Non-small Cell Lung Cancer
Silvestri, G. A., Gould, M. K., Margolis, M. L., Tanoue, L. T., McCrory, D., Toloza, E., & Detterbeck, F. (2007) · Chest · doi:10.1378/chest.07-1360 · Cited by 622
Patz, E. F., Goodman, P. C., & Bepler, G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432208 · Cited by 599
Detection and Clinical Importance of Micrometastatic Disease
Pantel, K., Cote, R. J., & Fodstad, O. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.13.1113 · Cited by 493
Self-citationReview: Biological relevance of disseminated tumor cells in cancer patients
Riethdorf, S., Wikman, H., & Pantel, K. (2008) · International Journal of Cancer · doi:10.1002/ijc.23825 · Cited by 309
Metadata
- Authors
- Cote, R. J., Beattie, E. J., Chaiwun, B., Shi, S.-R., Harvey, J., Chen, S.-C., Sherrod, A. E., Groshen, S., & Taylor, C. R.
- Venue
- Annals of Surgery
- Published
- 1995-10
- Volume
- 222
- Issue
- 4
- Pages
- 415-425
- ISSN
- 0003-4932 (ISSN-L)
- OpenAlex
- W1998881872
- Cited by
- 166
- References
- 0
- FWCI
- 4.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Detection of Occult Bone Marrow Micrometastases in Patients with Operable Lung Carcinoma. https://app.cochat.ai/papers/10.1097/00000658-199510000-00001
- The paper
- Cote, R. J., Beattie, E. J., Chaiwun, B., Shi, S.-R., Harvey, J., Chen, S.-C., Sherrod, A. E., Groshen, S., & Taylor, C. R. (1995). Detection of Occult Bone Marrow Micrometastases in Patients with Operable Lung Carcinoma. Annals of Surgery. https://doi.org/10.1097/00000658-199510000-00001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.